Clinical Trial Update: Antithymocyte Globulin and Cyclosporine to Treat Myelodysplasia [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluated antithymocyte globulin plus cyclosporine for myelodysplastic syndrome; the study is completed with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndrome

Drugs mentioned

• Antithymocyte Globulin (anti-thymocyte globulin)
• CYCLOSPORINE (cyclosporine)

Snippet

Sponsor: Neal Young, M.D. | Conditions: Myelodysplastic Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2014-10-23